The soluble guanylyl cyclase pathway is inhibited to evade androgen deprivation-induced senescence and enable progression to castration resistance
P. Rai, L. Zhang, C. I. Troccoli, B. Mateo-Victoriano, L. Misiara, E. N. Jackson, P. Shu, T. M. Plastini, W. Tao, D. Kwon, X. Chen, J. Sharma, M. Jorda, J. L. Gulley, M. Bilusic, , A. Beuve
This study identifies the soluble guanylyl cyclase (sGC) pathway as a target for castration-resistant prostate cancer (CRPC) treatment, showing that riociguat inhibits CRPC growth and enhances radiation response.
bioRxiv · May 3, 2023 · PreprintCancer Biology